GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PPD Inc (NAS:PPD) » Definitions » Market Cap

PPD (PPD) Market Cap : $16,614 Mil (As of May. 06, 2024)


View and export this data going back to 2020. Start your Free Trial

What is PPD Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). PPD's share price for the quarter that ended in Sep. 2021 was $46.79. PPD's Shares Outstanding (EOP) for the quarter that ended in Sep. 2021 was 351 Mil. Therefore, PPD's market cap for the quarter that ended in Sep. 2021 was $16,442 Mil.

PPD's quarterly market cap increased from Mar. 2021 ($13,279 Mil) to Jun. 2021 ($16,192 Mil) and increased from Jun. 2021 ($16,192 Mil) to Sep. 2021 ($16,442 Mil).

PPD's annual market cap stayed the same from Dec. 2018 ($0 Mil) to Dec. 2019 ($0 Mil) but then increased from Dec. 2019 ($0 Mil) to Dec. 2020 ($11,982 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. PPD's Enterprise Value for Today is $19,856 Mil.


PPD Market Cap Historical Data

The historical data trend for PPD's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PPD Market Cap Chart

PPD Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20
Market Cap
- - - - 11,981.52

PPD Quarterly Data
Dec16 Dec17 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12,930.41 11,981.52 13,279.38 16,191.97 16,441.54

Competitive Comparison of PPD's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, PPD's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PPD's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PPD's Market Cap distribution charts can be found below:

* The bar in red indicates where PPD's Market Cap falls into.



PPD Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

PPD's Market Cap for the fiscal year that ended in Dec. 2020 is calculated as

Market Cap (A: Dec. 2020 )=Share Price (A: Dec. 2020 )*Shares Outstanding (EOP) (A: Dec. 2020 )
=$34.22*350.132
=$11,982

PPD's Market Cap for the quarter that ended in Sep. 2021 is calculated as

Market Cap (Q: Sep. 2021 )=Share Price (Q: Sep. 2021 )*Shares Outstanding (EOP) (Q: Sep. 2021 )
=$46.79*351.39
=$16,442

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PPD  (NAS:PPD) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


PPD Market Cap Related Terms

Thank you for viewing the detailed overview of PPD's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


PPD (PPD) Business Description

Traded in Other Exchanges
N/A
Address
929 North Front Street, Wilmington, NC, USA, 28401
PPD is a global contract research organization that provides clinical trial and laboratory services to pharmaceutical, device, and diagnostic firms. The clinical development services segment offers outsourced trial services, spanning early- and late-stage trials, as well as peri- and post-approval trials, and the laboratory services segment includes both advanced lab testing and central lab services. The company was taken private in 2011 and went public again in 2020.. Thermo Fisher Scientific announced it will acquire PPD for $17.4 billion, which is scheduled to close by the end of 2021.
Executives
H&f Corporate Investors Viii, Ltd. 10 percent owner 415 MISSION STREET, SUITE 5700, SAN FRANCISCO CA 94105
H&f Corporate Investors Vii, Ltd. 10 percent owner 415 MISSION STREET, SUITE 5700, SAN FRANCISCO CA 94105
David Michael Johnston officer: See Remarks C/O PPD, INC. 929 NORTH FRONT STREET WILMINGTON NC 28401
David S Simmons director, officer: Chief Executive Officer PFIZER INC. ATTN. CORP. SECRETARY, 235 EAST 42ND STREET, NEW YORK NY 10017
Glen Donovan officer: Chief Accounting Officer C/O PPD, INC. 929 NORTH FRONT STREET WILMINGTON NC 28401
Ronald E Garrow officer: See Remarks 2000 PURCHASE STREET, PURCHASE NY 10577
Karen Kaucic officer: See Remarks C/O PPD, INC. 929 NORTH FRONT STREET WILMINGTON NC 28401
Judd Hartman officer: See Remarks 3124 DEVER COURT WILMINGTON NC 28411
Jill Pellegrino officer: SVP & General Manager of AES C/O PPD, INC. 929 NORTH FRONT STREET WILMINGTON NC 28401
H&f Executives Vii, L.p. 10 percent owner ONE MARITIME PLAZA 12TH FLOOR SAN FRANCISCO CA 94111
Hellman & Friedman Investors Viii, L.p. 10 percent owner 415 MISSION STREET, SUITE 5700, SAN FRANCISCO CA 94105
P. Hunter Philbrick director C/O HELLMAN & FRIEDMAN INVESTORS, ONE MARTIME PLAZA, 12TH FLOOR, SAN FRANCISCO CA 94111
Carlyle Partners Vi Holdings Ii, L.p. 10 percent owner C/O THE CARLYLE GROUP, SUITE 220 SOUTH 1001 PENNSYLVANIA AVENUE, N.W. WASHINGTON DC 20004
Tc Group Vi, L.l.c. 10 percent owner C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA ANVENE, N.W., WASHINGTON DC 20004
Tc Group Vi, L.p. 10 percent owner C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004

PPD (PPD) Headlines

From GuruFocus

PPD Opens Multipurpose Clinical Research Laboratory in Suzhou, China

By Business Wire Business Wire 05-24-2021

PPD Announces Third Quarter 2021 Earnings Conference Call

By Business Wire Business Wire 10-18-2021